miR-215-5p, for example, inhibits prostate cancer metastasis by targeting PGK1, whereas miR-671-5p increases prostate cancer metastasis by targeting the NFIA/CRYAB axis. The gene discussed is PGK1; the disease is prostate carcinoma.